Skip to main content
Top
Published in: Medical Gas Research 1/2011

Open Access 01-12-2011 | Research

Effect of an hyperbaric nitrogen narcotic ambience on arginine and citrulline levels, the precursor and co-product of nitric oxide, in rat striatum

Authors: Nicolas Vallée, Jean-Jacques Rissoe, Jean-Eric Blatteau

Published in: Medical Gas Research | Issue 1/2011

Login to get access

Abstract

Previous studies performed in the laboratory have shown that nitrogen narcosis induces a decrease in striatal glutamate and dopamine levels. Although we stimulated the N-methyl-D-aspartate (NMDA) receptor, an important glutamate receptor required for motor and locomotor activity managed by the striatum, and demonstrated that the receptor was effective when exposed to nitrogen at 3MPa, it was not possible to return the striatal glutamate level to its base values. We conclude that it was the striatopetal neurons of the glutamatergic pathways that were mainly affected in this hyperbaric syndrome, without understanding the principal reasons. Hence we sought to establish what happens in the vicinity of the plasma membrane, downstream the NMDA-Receptor, and we used the hypothesis that there could be neuronal nitric oxide synthase (nNOS) disturbances. A microdialysis study was performed in rat striatum in order to analyse levels of citrulline, the NO co-product, and arginine, the NO precursor. Those both NO metabolites were detectable with an HPLC coupled to a fluorimetric detector. Exposure to pressurized nitrogen induced a reduction in citrulline (-18.9%) and arginine (-10.4%) levels. Under the control normobaric conditions, the striatal NMDA infusion enhanced the citrulline level (+85.6%), whereas under 3 MPa of nitrogen, the same NMDA infusion did not change the citrulline level which remains equivalent to that of the baseline. The level of arginine increased (+45.7%) under normobaric conditions but a decrease occurred in pressurized nitrogen (-51.6%). Retrodialysis with Saclofen and KCl in the prefrontal cortex under normobaric conditions led to an increase in striatal levels of citrulline (+30.5%) and a decrease in arginine levels (-67.4%). There was no significant difference when nitrogen at 3MPa was added. To conclude, the synthesis of citrulline/NO is reduced in nitrogen narcosis while it seems possible to activate it artificially by infusion. We have suggested that the low glutamate levels recorded in nitrogen narcosis induced these dopamine and NO reductions in the striatum.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bennett PB, Rostain JC: Inert gas narcosis. Bennett and Elliott's physiology and medicine of diving. Edited by: Brubbakk AO, Neuman TS. 2003, Saunders Company Ltd., London, 300-322. Bennett PB, Rostain JC: Inert gas narcosis. Bennett and Elliott's physiology and medicine of diving. Edited by: Brubbakk AO, Neuman TS. 2003, Saunders Company Ltd., London, 300-322.
2.
go back to reference Dedieu D, Balon N, Weiss M, Risso JJ, Kinkead R, Rostain JC: Microdialysis study of striatal dopaminergic dysfunctions induced by 3 MPa of nitrogen- and helium-oxygen breathing mixtures in freely moving rats. Brain Res. 2004, 998: 202-207. 10.1016/j.brainres.2003.11.026.CrossRefPubMed Dedieu D, Balon N, Weiss M, Risso JJ, Kinkead R, Rostain JC: Microdialysis study of striatal dopaminergic dysfunctions induced by 3 MPa of nitrogen- and helium-oxygen breathing mixtures in freely moving rats. Brain Res. 2004, 998: 202-207. 10.1016/j.brainres.2003.11.026.CrossRefPubMed
3.
go back to reference Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ: Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg. 2003, 96: 746-749.CrossRefPubMed Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ: Gamma-aminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg. 2003, 96: 746-749.CrossRefPubMed
4.
go back to reference Vallée N, Rostain JC, Boussuges A, Risso JJ: Comparison of nitrogen narcosis and helium pressure effects on striatal amino acids: a microdialysis study in rats. Neurochem Res. 2009, 34: 835-844. 10.1007/s11064-008-9827-1.CrossRefPubMed Vallée N, Rostain JC, Boussuges A, Risso JJ: Comparison of nitrogen narcosis and helium pressure effects on striatal amino acids: a microdialysis study in rats. Neurochem Res. 2009, 34: 835-844. 10.1007/s11064-008-9827-1.CrossRefPubMed
5.
go back to reference Vallée N, Rostain JC, Risso JJ: How can an inert gas counterbalance a NMDA-induced glutamate release?. J Appl Physiol. 2009, 107: 1951-1958. 10.1152/japplphysiol.00097.2009.CrossRefPubMed Vallée N, Rostain JC, Risso JJ: How can an inert gas counterbalance a NMDA-induced glutamate release?. J Appl Physiol. 2009, 107: 1951-1958. 10.1152/japplphysiol.00097.2009.CrossRefPubMed
6.
go back to reference Vallée N, Rostain JC, Risso JJ: A Pressurized Nitrogen Counterbalance to Cortical Glutamatergic Pathway Stimulation. Neurochem Res. 2010, 35: 718-726. 10.1007/s11064-010-0125-3.CrossRefPubMed Vallée N, Rostain JC, Risso JJ: A Pressurized Nitrogen Counterbalance to Cortical Glutamatergic Pathway Stimulation. Neurochem Res. 2010, 35: 718-726. 10.1007/s11064-010-0125-3.CrossRefPubMed
7.
go back to reference Lavoute C, Weiss M, Rostain JC: Effects of NMDA administration in the substantia nigra pars compacta on the striatal dopamine release before and after repetitive exposures to nitrogen narcosis in rats. Undersea Hyperb Med. 2006, 33: 175-179.PubMed Lavoute C, Weiss M, Rostain JC: Effects of NMDA administration in the substantia nigra pars compacta on the striatal dopamine release before and after repetitive exposures to nitrogen narcosis in rats. Undersea Hyperb Med. 2006, 33: 175-179.PubMed
8.
go back to reference Lavoute C, Weiss M, Rostain JC: The role of NMDA and GABA(A) receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level. Brain Res. 2007, 1176: 37-44.CrossRefPubMed Lavoute C, Weiss M, Rostain JC: The role of NMDA and GABA(A) receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level. Brain Res. 2007, 1176: 37-44.CrossRefPubMed
9.
go back to reference Vjotosh A, Popov A, Alekseeva O: Role of nitric oxide in the mechanism of nitrogen narcosis. Undersea Hyperb Med. 1999, 26: 81- Vjotosh A, Popov A, Alekseeva O: Role of nitric oxide in the mechanism of nitrogen narcosis. Undersea Hyperb Med. 1999, 26: 81-
10.
go back to reference Kendrick KM, Guevara-Guzman R, de la Riva C, Christensen J, Ostergaard K, Emson PC: NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur J Neurosci. 1996, 8: 2619-2634. 10.1111/j.1460-9568.1996.tb01557.x.CrossRefPubMed Kendrick KM, Guevara-Guzman R, de la Riva C, Christensen J, Ostergaard K, Emson PC: NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur J Neurosci. 1996, 8: 2619-2634. 10.1111/j.1460-9568.1996.tb01557.x.CrossRefPubMed
11.
go back to reference Kendrick KM, Guevara-Guzman R, Zorrilla J, Hinton MR, Broad KD, Ohkura S: Formation of olfactory memories mediated by nitric oxide. Nature. 1997, 388: 670-674. 10.1038/41765.CrossRefPubMed Kendrick KM, Guevara-Guzman R, Zorrilla J, Hinton MR, Broad KD, Ohkura S: Formation of olfactory memories mediated by nitric oxide. Nature. 1997, 388: 670-674. 10.1038/41765.CrossRefPubMed
12.
go back to reference Kaehler S, Singewald N, Sinner C, Philippu A: Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res. 1999, 835: 346-349. 10.1016/S0006-8993(99)01599-1.CrossRefPubMed Kaehler S, Singewald N, Sinner C, Philippu A: Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res. 1999, 835: 346-349. 10.1016/S0006-8993(99)01599-1.CrossRefPubMed
13.
go back to reference Wegener G, Volke V, Rosenberg R: Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol. 2000, 130: 575-580. 10.1038/sj.bjp.0703349.PubMedCentralCrossRefPubMed Wegener G, Volke V, Rosenberg R: Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol. 2000, 130: 575-580. 10.1038/sj.bjp.0703349.PubMedCentralCrossRefPubMed
14.
go back to reference Micheva KD, Buchanan J, Holz RW, Smith SJ: Retrograde regulation of synaptic vesicle endocytosis and recycling. Nat Neurosci. 2003, 6: 925-932. 10.1038/nn1114.CrossRefPubMed Micheva KD, Buchanan J, Holz RW, Smith SJ: Retrograde regulation of synaptic vesicle endocytosis and recycling. Nat Neurosci. 2003, 6: 925-932. 10.1038/nn1114.CrossRefPubMed
15.
go back to reference Trabace L, Cassano T, Tucci P, Steardo L, Kendrick KM, Cuomo V: The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat. Brain Res. 2004, 1008: 293-298. 10.1016/j.brainres.2004.01.090.CrossRefPubMed Trabace L, Cassano T, Tucci P, Steardo L, Kendrick KM, Cuomo V: The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat. Brain Res. 2004, 1008: 293-298. 10.1016/j.brainres.2004.01.090.CrossRefPubMed
16.
go back to reference Choi YB, Tenneti L, Le DA, Ortiz J, Bai G, Chen HS, Lipton SA: Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci. 2000, 3: 15-21. 10.1038/71090.CrossRefPubMed Choi YB, Tenneti L, Le DA, Ortiz J, Bai G, Chen HS, Lipton SA: Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci. 2000, 3: 15-21. 10.1038/71090.CrossRefPubMed
17.
go back to reference Collier J, Vallance P: Second messenger role for NO widens to nervous and immune systems. Trends Pharmacol Sci. 1989, 10: 427-431.CrossRefPubMed Collier J, Vallance P: Second messenger role for NO widens to nervous and immune systems. Trends Pharmacol Sci. 1989, 10: 427-431.CrossRefPubMed
18.
go back to reference Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH: Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA. 1991, 88: 7797-7801. 10.1073/pnas.88.17.7797.PubMedCentralCrossRefPubMed Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH: Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA. 1991, 88: 7797-7801. 10.1073/pnas.88.17.7797.PubMedCentralCrossRefPubMed
19.
go back to reference Snyder GL, Girault JA, Chen JY, Czernik AJ, Kebabian JW, Nathanson JA, Greengard P: Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J Neurosci. 1992, 12: 3071-3083.PubMed Snyder GL, Girault JA, Chen JY, Czernik AJ, Kebabian JW, Nathanson JA, Greengard P: Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J Neurosci. 1992, 12: 3071-3083.PubMed
20.
go back to reference Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L: Nitric oxide-induced blockade of NMDA receptors. Neuron. 1992, 8: 653-662. 10.1016/0896-6273(92)90087-T.CrossRefPubMed Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L: Nitric oxide-induced blockade of NMDA receptors. Neuron. 1992, 8: 653-662. 10.1016/0896-6273(92)90087-T.CrossRefPubMed
21.
go back to reference Fagni L, Lafon-Cazal M, Lerner-Natoli M, Rondouin G, Bockaert J: The role of nitric oxide and superoxides in the neurotoxicity of glutamate. J Pharm Belg. 1995, 50: 204-212.PubMed Fagni L, Lafon-Cazal M, Lerner-Natoli M, Rondouin G, Bockaert J: The role of nitric oxide and superoxides in the neurotoxicity of glutamate. J Pharm Belg. 1995, 50: 204-212.PubMed
22.
go back to reference Brenman JE, Bredt DS: Synaptic signaling by nitric oxide. Current opinion in neurobiology. 1997, 7: 374-378. 10.1016/S0959-4388(97)80065-7.CrossRefPubMed Brenman JE, Bredt DS: Synaptic signaling by nitric oxide. Current opinion in neurobiology. 1997, 7: 374-378. 10.1016/S0959-4388(97)80065-7.CrossRefPubMed
23.
go back to reference Christoffersen CL, Meltzer LT: Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neuroscience. 1995, 67: 373-381. 10.1016/0306-4522(95)00047-M.CrossRefPubMed Christoffersen CL, Meltzer LT: Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neuroscience. 1995, 67: 373-381. 10.1016/0306-4522(95)00047-M.CrossRefPubMed
24.
go back to reference Garthwaite J, Boulton CL: Nitric oxide signaling in the central nervous system. Annual review of physiology. 1995, 57: 683-706. 10.1146/annurev.ph.57.030195.003343.CrossRefPubMed Garthwaite J, Boulton CL: Nitric oxide signaling in the central nervous system. Annual review of physiology. 1995, 57: 683-706. 10.1146/annurev.ph.57.030195.003343.CrossRefPubMed
25.
go back to reference Chaparro-Huerta V, Beas-Zarate C, Guerrero MU, Feria-Velasco A: Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain. Neurochem Int. 1997, 31: 607-616. 10.1016/S0197-0186(96)00141-6.CrossRefPubMed Chaparro-Huerta V, Beas-Zarate C, Guerrero MU, Feria-Velasco A: Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain. Neurochem Int. 1997, 31: 607-616. 10.1016/S0197-0186(96)00141-6.CrossRefPubMed
26.
go back to reference Silva MT, Rose S, Hindmarsh JG, Jenner P: Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum. J Neural Transm. 2003, 110: 353-362. 10.1007/s00702-002-0791-7.CrossRefPubMed Silva MT, Rose S, Hindmarsh JG, Jenner P: Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum. J Neural Transm. 2003, 110: 353-362. 10.1007/s00702-002-0791-7.CrossRefPubMed
27.
go back to reference Grima G, Cuenod M, Pfeiffer S, Mayer B, Do KQ: Arginine availability controls the N-methyl-D-aspartate-induced nitric oxide synthesis: involvement of a glial-neuronal arginine transfer. J Neurochem. 1998, 71: 2139-2144.CrossRefPubMed Grima G, Cuenod M, Pfeiffer S, Mayer B, Do KQ: Arginine availability controls the N-methyl-D-aspartate-induced nitric oxide synthesis: involvement of a glial-neuronal arginine transfer. J Neurochem. 1998, 71: 2139-2144.CrossRefPubMed
28.
go back to reference Morari M, Sbrenna S, Marti M, Caliari F, Bianchi C, Beani L: NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms. J Neurochem. 1998, 71: 2006-2017.CrossRefPubMed Morari M, Sbrenna S, Marti M, Caliari F, Bianchi C, Beani L: NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms. J Neurochem. 1998, 71: 2006-2017.CrossRefPubMed
29.
go back to reference Braissant O, Gotoh T, Loup M, Mori M, Bachmann C: L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res. 1999, 70: 231-241.CrossRefPubMed Braissant O, Gotoh T, Loup M, Mori M, Bachmann C: L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res. 1999, 70: 231-241.CrossRefPubMed
30.
go back to reference Kawaguchi Y: Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci. 1993, 13: 4908-4923.PubMed Kawaguchi Y: Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci. 1993, 13: 4908-4923.PubMed
31.
go back to reference Prast H, Philippu A: Nitric oxide as modulator of neuronal function. Prog Neurobiol. 2001, 64: 51-68. 10.1016/S0301-0082(00)00044-7.CrossRefPubMed Prast H, Philippu A: Nitric oxide as modulator of neuronal function. Prog Neurobiol. 2001, 64: 51-68. 10.1016/S0301-0082(00)00044-7.CrossRefPubMed
32.
go back to reference Martinelli GP, Friedrich VL, Holstein GR: L-citrulline immunostaining identifies nitric oxide production sites within neurons. Neuroscience. 2002, 114: 111-122. 10.1016/S0306-4522(02)00238-5.CrossRefPubMed Martinelli GP, Friedrich VL, Holstein GR: L-citrulline immunostaining identifies nitric oxide production sites within neurons. Neuroscience. 2002, 114: 111-122. 10.1016/S0306-4522(02)00238-5.CrossRefPubMed
33.
go back to reference Schmidlin A, Fischer S, Wiesinger H: Transport of L-citrulline in neural cell cultures. Dev Neurosci. 2000, 22: 393-398. 10.1159/000017468.CrossRefPubMed Schmidlin A, Fischer S, Wiesinger H: Transport of L-citrulline in neural cell cultures. Dev Neurosci. 2000, 22: 393-398. 10.1159/000017468.CrossRefPubMed
34.
go back to reference Paxinos G, Watson C: The rat brain in stereotaxic coordinates. 1986, Academic press New York Paxinos G, Watson C: The rat brain in stereotaxic coordinates. 1986, Academic press New York
35.
go back to reference Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM: Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 2004, 27: 468-474. 10.1016/j.tins.2004.06.006.CrossRefPubMed Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM: Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 2004, 27: 468-474. 10.1016/j.tins.2004.06.006.CrossRefPubMed
36.
37.
go back to reference Torregrossa MM, Tang XC, Kalivas PW: The glutamatergic projection from the prefrontal cortex to the nucleus accumbens core is required for cocaine-induced decreases in ventral pallidal GABA. Neurosci Lett. 2008, 438: 142-145. 10.1016/j.neulet.2008.04.016.PubMedCentralCrossRefPubMed Torregrossa MM, Tang XC, Kalivas PW: The glutamatergic projection from the prefrontal cortex to the nucleus accumbens core is required for cocaine-induced decreases in ventral pallidal GABA. Neurosci Lett. 2008, 438: 142-145. 10.1016/j.neulet.2008.04.016.PubMedCentralCrossRefPubMed
38.
go back to reference Harte M, O'Connor WT: Evidence for a selective prefrontal cortical GABA(B) receptor-mediated inhibition of glutamate release in the ventral tegmental area: a dual probe microdialysis study in the awake rat. Neuroscience. 2005, 130: 215-222. 10.1016/j.neuroscience.2004.08.045.CrossRefPubMed Harte M, O'Connor WT: Evidence for a selective prefrontal cortical GABA(B) receptor-mediated inhibition of glutamate release in the ventral tegmental area: a dual probe microdialysis study in the awake rat. Neuroscience. 2005, 130: 215-222. 10.1016/j.neuroscience.2004.08.045.CrossRefPubMed
39.
go back to reference Clarkson DP, Schatte CL, Jordan JP: Thermal neutral temperature of rats in helium-oxygen, argon-oxygen, and air. Am J Physiol. 1972, 222: 1494-1498.PubMed Clarkson DP, Schatte CL, Jordan JP: Thermal neutral temperature of rats in helium-oxygen, argon-oxygen, and air. Am J Physiol. 1972, 222: 1494-1498.PubMed
40.
go back to reference Kuiper MA, Teerlink T, Visser JJ, Bergmans PL, Scheltens P, Wolters EC: L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. J Neural Transm. 2000, 107: 183-189. 10.1007/s007020050016.CrossRefPubMed Kuiper MA, Teerlink T, Visser JJ, Bergmans PL, Scheltens P, Wolters EC: L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. J Neural Transm. 2000, 107: 183-189. 10.1007/s007020050016.CrossRefPubMed
41.
go back to reference Galley HF, Le Cras AE, Logan SD, Webster NR: Differential nitric oxide synthase activity, cofactor availability and cGMP accumulation in the central nervous system during anaesthesia. Br J Anaesth. 2001, 86: 388-394. 10.1093/bja/86.3.388.CrossRefPubMed Galley HF, Le Cras AE, Logan SD, Webster NR: Differential nitric oxide synthase activity, cofactor availability and cGMP accumulation in the central nervous system during anaesthesia. Br J Anaesth. 2001, 86: 388-394. 10.1093/bja/86.3.388.CrossRefPubMed
42.
go back to reference Goren MZ, Aricioglu-Kartal F, Yurdun T, Uzbay IT: Investigation of extracellular L-citrulline concentration in the striatum during alcohol withdrawal in rats. Neurochem Res. 2001, 26: 1327-1333. 10.1023/A:1014253618835.CrossRefPubMed Goren MZ, Aricioglu-Kartal F, Yurdun T, Uzbay IT: Investigation of extracellular L-citrulline concentration in the striatum during alcohol withdrawal in rats. Neurochem Res. 2001, 26: 1327-1333. 10.1023/A:1014253618835.CrossRefPubMed
43.
go back to reference Hallemeesch MM, Lamers WH, Deutz NE: Reduced arginine availability and nitric oxide production. Clin Nutr. 2002, 21: 273-279. 10.1054/clnu.2002.0571.CrossRefPubMed Hallemeesch MM, Lamers WH, Deutz NE: Reduced arginine availability and nitric oxide production. Clin Nutr. 2002, 21: 273-279. 10.1054/clnu.2002.0571.CrossRefPubMed
44.
go back to reference Brunetti L, Volpe AR, Ragazzoni E, Preziosi P, Vacca M: Interleukin-1 beta specifically stimulates nitric oxide production in the hypothalamus. Life Sci. 1996, 58: L373-377.CrossRef Brunetti L, Volpe AR, Ragazzoni E, Preziosi P, Vacca M: Interleukin-1 beta specifically stimulates nitric oxide production in the hypothalamus. Life Sci. 1996, 58: L373-377.CrossRef
45.
go back to reference Schmidlin A, Kalbacher H, Wiesinger H: Presence of argininosuccinate synthetase in glial cells as revealed by peptide-specific antisera. Biol Chem. 1997, 378: 47-50. 10.1515/bchm.1997.378.1.47.CrossRefPubMed Schmidlin A, Kalbacher H, Wiesinger H: Presence of argininosuccinate synthetase in glial cells as revealed by peptide-specific antisera. Biol Chem. 1997, 378: 47-50. 10.1515/bchm.1997.378.1.47.CrossRefPubMed
46.
go back to reference Silva MT, Rose S, Hindmarsh JG, Jenner P, Marsden CD: L-arginine produces NO-independent increases in dopamine efflux in rat striatum. Neuroreport. 1998, 9: 149-152. 10.1097/00001756-199801050-00030.CrossRefPubMed Silva MT, Rose S, Hindmarsh JG, Jenner P, Marsden CD: L-arginine produces NO-independent increases in dopamine efflux in rat striatum. Neuroreport. 1998, 9: 149-152. 10.1097/00001756-199801050-00030.CrossRefPubMed
47.
go back to reference Palmer RM, Rees DD, Ashton DS, Moncada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988, 153: 1251-1256. 10.1016/S0006-291X(88)81362-7.CrossRefPubMed Palmer RM, Rees DD, Ashton DS, Moncada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988, 153: 1251-1256. 10.1016/S0006-291X(88)81362-7.CrossRefPubMed
48.
go back to reference Balon N, Kriem B, Dousset E, Weiss M, Rostain JC: Opposing effects of narcotic gases and pressure on the striatal dopamine release in rats. Brain Res. 2002, 947: 218-224. 10.1016/S0006-8993(02)02928-1.CrossRefPubMed Balon N, Kriem B, Dousset E, Weiss M, Rostain JC: Opposing effects of narcotic gases and pressure on the striatal dopamine release in rats. Brain Res. 2002, 947: 218-224. 10.1016/S0006-8993(02)02928-1.CrossRefPubMed
49.
go back to reference Vallée N, Rostain JC, Risso JJ: Low susceptibility to inert gases and pressure symptoms in TREK-1-deficient mice. Neuroreport. 2009, 20: 343-347. 10.1097/WNR.0b013e328322ca4d.CrossRefPubMed Vallée N, Rostain JC, Risso JJ: Low susceptibility to inert gases and pressure symptoms in TREK-1-deficient mice. Neuroreport. 2009, 20: 343-347. 10.1097/WNR.0b013e328322ca4d.CrossRefPubMed
Metadata
Title
Effect of an hyperbaric nitrogen narcotic ambience on arginine and citrulline levels, the precursor and co-product of nitric oxide, in rat striatum
Authors
Nicolas Vallée
Jean-Jacques Rissoe
Jean-Eric Blatteau
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Medical Gas Research / Issue 1/2011
Electronic ISSN: 2045-9912
DOI
https://doi.org/10.1186/2045-9912-1-16

Other articles of this Issue 1/2011

Medical Gas Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.